Vaccine Adjuvants Market 2019 Size, Share, Leading Growth Drivers, Emerging Audience, Segments, Industry Sales, Profits & Analysis

Posted December 5, 2019 by Sapanas

Global vaccines adjuvants market is expected to grow at a healthy CAGR of 10.1% during the forecast period 2017-2023.

Vaccine Adjuvants Market Information: By Type (Pathogen Components, Particulate Adjuvants, others), By Route of Administration (Oral, Intramuscular, Subcutaneous, and Intradermal), and By End Users (Pediatric, Adult) - Global Forecast Till 2023

Vaccine Adjuvants Market Overview

Market Research Future has a half cooked research report on the global vaccine adjuvants market.

Vaccine adjuvants instruct the immune system further in launching a countermeasure against the infection. These immunological agents modify the effect of other agents by enhancing the vaccine development process, striking a strong and prominant immune response to the administered antigen (Immunology) and a strong protection against infection. Adjuvants have come up as a vital component for most of the clinically used vaccines.

Understanding the application of adjuvants is very essential in analyzing the market dynamics. Several developments are taking place in the antigen research (vaccine). These research and development activities have also been helpful in driving the market growth of vaccine adjuvants.

Market Research Future (MRFR) in its recently published study report asserts that the global vaccine adjuvants market is expected to perceive exponential gains by 2022. It has been noted that the market growing at a steady pace will post a CAGR of 10.1% during the forecasted period 2017 – 2023. Surpassing its previous growth records in terms of value & volume, the market is expected to gain prominence over the forecasted period.

Get a FREE Sample Copy of Report with Complete TOC @

Factors influencing the market growth include the increasing government initiatives, proposals and vaccination drives such as Polio, mechanical advancements, and manufactured immunizations. Immunization programs that government bodies are focusing upon are also expected to drive the demand for vaccine adjuvants. Increase in zoonotic and infectious diseases, along with the demand for improved vaccination against existing and emerging diseases foster the market growth extensively.

Additionally, the increasing use of synthetic vaccines and recombinant are also expected to drive the global vaccine adjuvants market over the forecast period.

On the other hand, factors such as high toxicity adjuvants, side effects, stringent regulatory aspects, cost of developing a new adjuvant, lack of awareness about adjuvants and unmet vaccine requirements for specific diseases, are obstructing the market growth.

Next generation adjuvants: Rapid progress in molecular immunology has advanced vaccine adjuvant discovery efforts, enabling the use of cellular and target-based assays to screen an array of chemical compounds for potential use as immune potentiators. How to deliver these new adjuvant compounds is the challenge, particularly for use in existing vaccines which are commonly used as adjuvants e.g. Insoluble aluminum salts.

A recently discovered adjuvant active compounds called Small Molecule Immune Potentiators (SMIPs) which enable adsorption of aluminum hydroxide adjuvant via the mechanism of ligand exchange. It is a novel approach and an overview of in-vitro and in-vivo performance of the new generation adjuvants.

Global Vaccine Adjuvants Market – Segmentations

The MRFR analysis segmented into four key dynamics for the convenience of the report and enhanced understanding;

By Types: Pathogen Components, Particulate Adjuvants, others.

By Routes of Administration: Oral, Intramuscular, Subcutaneous, and Intradermal.

By End-Users: Pediatric and Adults

By Regions: North America, Europe, APAC and Rest-of-the-World.

Vaccine Adjuvants Market – Regional Analysis
North America dominated the Global Vaccine Adjuvants market with the largest market share, accounting for a fabulous growth records and is expected to grow further by 2023. A proliferated healthcare sector, well-spread awareness towards the benefits of vaccination in preventing the communicable and non-communicable diseases and favorable conditions for research and development are some of the factors substantiating the market growth in region.

The European market for vaccine adjuvants is expected to grow at a substantial GAGR during 2017-2023, closely following the North American market. Factors such as the availability of funds for research and development activities, and growing initiatives taken by the government and NGOs for diseases preventive measures are fostering the market growth.

Asia Pacific is expected to grow at a considerable CAGR during 2017 – 2023, emerging as one of the most lucrative markets for vaccine adjuvants. Increasing prevalence of communicable diseases in the region is the dominant driving force for the market growth. India and China backed by the improvement in the healthcare domain, and increasing prevalence of diseases are providing impetus to the market growth in the APAC.

The market in the Middle East & Africa region will witness a sluggish growth due to lack of awareness, poor medical facilities, and less emphasis on research and development activities.

Global Vaccine Adjuvants Market – Competitive Analysis

Matured players having a strong foothold in the global and regional market adorn the global Vaccine Adjuvants market as highly competitive and fragmented. The vaccine adjuvants market is no exception when it comes to adopting strategies and trends, to churn the competitive advantage to sustain the market position.

They adopt the same prevailing trends such as M&A or strategic collaboration, investments in local manufacturers in developing nations, product developments and manufacturing activities. Also, some pharmaceutical giants have invested heavily in the field of Vaccine Adjuvants, which has interpreted as a capacity expansion plan and intensive R&D with the aim of obtaining vast growth opportunities.

Key Players

Vaxine Pty Ltd (Australia), VaxLiant LLC.(US),Aphios Corporation (US), Adjuvatis (France), Viscogel AB (Sweden), Sergeant Adjuvants (US), CureVac AG (Germany), Sigma-Aldrich Co. LLC.(India), Brenntag Biosector (Denmark), SEPPIC (France), CSL Limited (Australia), Agenus, Inc. (US), SPI Pharma, Inc.(US), Novavax, Inc.(US), Avanti Polar Lipids, Inc. (US), Invivogen (US), OZ Biosciences (France), and MPV Technologies (US) are some of the key players profiled in the MRFR Analysis.

Get More Information on Vaccine Adjuvants Market Research Report - Global forecast till 2023 @

Industry and Related News:

July 11, 2018 – Scientists at Trinity University Dublin, (Ireland) published their new research about the new adjuvant they developed in The Journal of Immunology. The adjuvant can kick-start the immature infant’s immune system and can be helpful while administering vaccines to infants and newborns.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Sapanas
Phone 6468459312
Business Address Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Country India
Categories Health , Industry , Medical
Tags Vaccine Adjuvants Market , Vaccine Adjuvants Market Size , Vaccine Adjuvants Market Share , Vaccine Adjuvants Market Growth , Vaccine Adjuvants Market Analysis , Vaccine Adjuvants Market Trends , Vaccine Adjuvants Industry
Last Updated December 5, 2019